Comparative Pharmacology
Head-to-head clinical analysis: AUVI Q versus EPIPEN E Z PEN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AUVI Q versus EPIPEN E Z PEN.
AUVI-Q vs EPIPEN E Z PEN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Epinephrine is a direct-acting sympathomimetic amine that acts on alpha- and beta-adrenergic receptors. Alpha-adrenergic stimulation increases peripheral vascular resistance, reversing hypotension and improving coronary perfusion. Beta-adrenergic stimulation causes bronchodilation, positive chronotropic and inotropic effects, and vasodilation.
Epinephrine is a direct-acting sympathomimetic amine that acts on alpha- and beta-adrenergic receptors. Alpha-adrenergic stimulation increases peripheral vascular resistance, reversing hypotension and improving coronary perfusion. Beta-adrenergic stimulation causes bronchodilation, positive inotropy, and chronotropy.
0.3 mg intramuscularly into anterolateral thigh, repeated every 5-15 minutes as needed.
0.3 mg intramuscularly every 5-15 minutes as needed for anaphylaxis. Administer into anterolateral thigh.
None Documented
None Documented
The terminal elimination half-life of epinephrine is approximately 2–3 minutes when administered intravenously. After intramuscular injection, the half-life is extended to about 20–30 minutes due to slower absorption, providing a longer duration of therapeutic effect.
The terminal elimination half-life of epinephrine is approximately 2-3 minutes when administered intravenously. The short half-life necessitates repeated doses or continuous infusion for sustained effect.
Epinephrine is rapidly metabolized in the liver and other tissues by catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO). Renal excretion of metabolites accounts for the majority of elimination; less than 5% is excreted unchanged in urine.
Epinephrine is rapidly metabolized in the liver and other tissues by catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO). Approximately 80-90% of an intravenous dose is excreted in the urine as inactive metabolites (metanephrine, vanillylmandelic acid, 3,4-dihydroxymandelic acid) with less than 5% excreted unchanged.
Category C
Category C
Adrenergic Agonist
Adrenergic Agonist